VGX-1027

DRUG2 trials

Sponsors

VGX Pharmaceuticals, LLC

Conditions

Healthy

Phase 1

Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects

CompletedNCT00627120

VGX Pharmaceuticals, LLCHealthy

Start: 2008-02-29Target: 48Updated: 2009-01-09

Multiple-Dose Study of VGX-1027 in Healthy Subjects

CompletedNCT00760396

VGX Pharmaceuticals, LLCHealthy

Start: 2008-09-30End: 2009-04-30Updated: 2009-04-07